搜索临床试验以:IPI-145
总计5973个结果
-
Statens Serum InstitutBill and Melinda Gates Foundation; Syneos Health; Larix A/S; AJ Vaccines A/S完全的
-
Statens Serum InstitutBill and Melinda Gates Foundation; Larix A/S; Vaxtrials S.A.; AJ Vaccines A/S完全的
-
Celon Pharma SANational Center for Research and Development, Poland完全的
-
Fidec CorporationBill and Melinda Gates Foundation; Centers for Disease Control and Prevention完全的
-
Betta Pharmaceuticals Co., Ltd.尚未招聘
-
Constellation PharmaceuticalsThe Leukemia and Lymphoma Society完全的
-
Cornerstone Pharmaceuticals完全的
-
Fusion Pharmaceuticals Inc.终止乳腺癌 | 胃癌 | 大肠癌 | 卵巢癌 | 肺癌 | 晚期实体瘤 | 头颈部鳞状细胞癌 | 肝癌 | 膀胱癌 | 易感 FGFR3 基因改变 | FGFR3 | FGFR3 过表达 | FGFR3受体 | FGFR3 蛋白过表达美国, 澳大利亚
-
China National Biotec Group Company LimitedBeijing Institute of Biological Products Co Ltd.; Wuhan Institute of Biological Products Co.... 和其他合作者未知
-
Yale UniversityEdison Pharmaceuticals Inc; Rembrandt Foundation完全的
-
Vigonvita Life SciencesShanghai Institute of Materia Medica, Chinese Academy of Sciences完全的